Skip to main content
Elekta logo

Elekta — Investor Relations & Filings

Ticker · EKTA ISIN · SE0000163628 LEI · 54930044O54BK617EP80 ST Manufacturing
Filings indexed 1,124 across all filing types
Latest filing 2018-11-14 Regulatory Filings
Country SE Sweden
Listing ST EKTA

Elekta is a company specializing in precision radiation medicine. It develops and provides clinical solutions, including equipment and software, for treating cancer and brain disorders. The company's portfolio features linear accelerators, the Elekta Unity MR-Linac system, Leksell Gamma Knife for stereotactic radiosurgery, and comprehensive brachytherapy solutions. Elekta also offers oncology informatics software to support treatment planning and clinical workflow. A key focus is advancing adaptive radiotherapy, a personalized approach that utilizes real-time imaging to precisely target tumors and minimize exposure to healthy tissue, aiming to improve patient outcomes.

Recent filings

Filing Released Lang Actions
GenesisCare signs MoU for Versa HD cancer treatment systems and research agreement with Elekta
Regulatory Filings Classification · 1% confidence The document announces a significant business development: GenesisCare signing a Memorandum of Understanding (MoU) with Elekta for the purchase of cancer treatment systems, valued at approximately USD 60 million. It also mentions a separate research agreement. This type of announcement, detailing a major commercial transaction or strategic partnership that is not a standard periodic financial report (like 10-K or IR), typically falls under general corporate news or regulatory disclosure. Since the text is a press release format, detailing a major transaction, it is best classified as a general Regulatory Filing (RNS) as it is information Elekta is obliged to make public under EU Market Abuse Regulation, and it does not fit the specific definitions for M&A (TAR), Financing (CAP), or Earnings (ER). Given the context of a press release announcing a major contract, RNS is the most appropriate general regulatory disclosure category.
2018-11-14 English
GenesisCare tecknar avsiktsförklaring för Versa HD cancerbehandlingssystem och forskningsavtal med Elekta
M&A Activity Classification · 1% confidence The document is a press release announcing a significant business agreement between Elekta and GenesisCare regarding the sale of cancer treatment systems (Versa HD) and a research collaboration. It details the signing of a Letter of Intent (Avsiktsförklaring) valued at approximately $60 million. This type of announcement, detailing major commercial contracts, financing activities, or strategic partnerships, fits best under the 'Capital/Financing Update' category, as it involves a significant capital transaction and business expansion, even though it's not a traditional debt/equity financing event. It is not a full financial report (10-K, IR), an earnings release (ER), or a management discussion (MDA). Since it concerns a major commercial deal and investment in technology, CAP is the most appropriate fit among the provided options, as it relates to capital deployment and business structure changes. The final sentence mentions the information is disclosed under EU Market Abuse Regulation, typical for significant corporate news.
2018-11-14 Swedish
Elekta presents long-term strategy and financial scenario at capital markets day
Investor Presentation Classification · 1% confidence The document is titled 'Elekta presents long-term strategy and financial scenario at capital markets day'. It details strategic goals, financial scenarios (CAGR, EBITA margin improvement) for the period up to fiscal year 2022/23, and includes commentary from the CEO. This content is characteristic of an Investor Presentation (IP) or a presentation given at an investor event, which often overlaps with strategy updates. Since it is a presentation of strategy and financial outlook to investors, 'Investor Presentation' (IP) is the most fitting category. It is not a full Annual Report (10-K), an Earnings Release (ER) focusing only on past period results, or a Management Discussion & Analysis (MDA) which is typically a section within a larger report. The length (3468 chars) suggests it is the content itself, not just an announcement of publication (RPA).
2018-09-27 English
Elekta presenterar långsiktig strategi och finansiellt scenario på kapitalmarknadsdag
Investor Presentation Classification · 1% confidence The document is titled 'Elekta presenterar långsiktig strategi och finansiellt scenario på kapitalmarknadsdag' (Elekta presents long-term strategy and financial scenario at Capital Markets Day). It details a new long-term financial outlook (CAGR targets, EBITA margin improvement) and strategic vision presented during a specific corporate event (Capital Markets Day). This type of forward-looking strategic and financial guidance presentation, often involving management commentary and detailed plans, aligns best with an Investor Presentation (IP) or potentially a Management Report (MDA). Since it is a presentation of strategy and financial scenarios aimed at investors, Investor Presentation (IP) is the most precise fit. It is not a formal regulatory filing like 10-K or IR, nor is it a short announcement of a report (RPA/RNS).
2018-09-27 Swedish
Bulletin from Elekta’s annual general meeting 2018
AGM Information Classification · 1% confidence The document explicitly states it is a 'Bulletin from Elekta's annual general meeting 2018'. It details resolutions passed regarding dividends, adoption of financial statements, election of the Board of Directors, director fees, auditor re-election, remuneration guidelines, adoption of the Performance Share Plan 2018, and authorizations for share acquisition/transfer. These are all core activities and outcomes of an Annual General Meeting (AGM). Therefore, the classification is AGM-R.
2018-08-30 English
Kommuniké från Elektas årsstämma 2018
AGM Information Classification · 1% confidence The document is titled 'Kommuniké från Elektas årsstämma 2018' (Communiqué from Elekta's Annual General Meeting 2018). It details the resolutions passed at the meeting, including decisions on dividends, approval of financial statements, election of the board, auditor appointments, remuneration guidelines, and the introduction of a new stock program. These are all typical outcomes and announcements made during or immediately following an Annual General Meeting (AGM). Therefore, the classification should be AGM-R (AGM Information). The document is a summary of the decisions, not a proxy statement (PSI) or a full annual report (10-K).
2018-08-30 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.